Atlas Trials

A Trial of SHR-1802 in Patients With Failure of Standard Treatment for Advanced Malignant Tumours

Clinical trial NCT04414150 · COMPLETED

Trial details

NCT number
NCT04414150
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Tumours
Start date
2020-06-17
Primary completion
2022-01-13
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.